Skip to main content
Fig. 3 | Cancer Imaging

Fig. 3

From: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Fig. 3

Individual bone marrow SUVmean changes between the pre-therapy and 3-week post-therapy scan evaluations. Patients are split according to the median pre-therapy SUVmean of 1.8., with longer PFS and OS observed for patients with higher pre-therapy bone marrow SUVmean. In general, the bone marrow SUVmean decreased post-therapy

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us